KLRC1 and COVID-19: As seen in Figure 5C, there was a significant enhancement of COVID-19 positive patient derived NK cell killing of SARS-CoV-2 infected Caco-2 cells with the addition of either NKG2A or KIR2DL1 blockade (p<0.05).